The recent contention of Apple Inc., challenging the decision of the Patent Trial and Appeal Board (PTAB) regarding the legitimacy of two patents held by Masimo Corp. is under scrutiny by Federal Circuit Judges. The patents in question pertain to blood oxygen measurement technology, which Apple is allegedly accused of infringing in a distinct lawsuit filed in California.
Wednesday’s proceedings witnessed the judges putting forth queries concerning Apple’s stance. The tech giant’s argument is that the PTAB erroneously upheld the validity of Masimo Corp.’s patents. This introspective approach taken by the law indicates the complex nature of patent laws dictating tech corporations and emphasizes the critical role the Federal Circuit court plays in shaping these interpretations.
Apple’s conflict with Masimo Corp. is a clear example of ongoing disputes centred around patent validity, infringement, and the boundaries of technology development; aspects holding central attention in high-stake corporate law disputes in today’s technologically engaged society.
Find more details about this development on the original Law360 report.